Literature DB >> 9002960

Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production.

L Meyaard1, E Hovenkamp, N Pakker, T C van der Pouw Kraan, F Miedema.   

Abstract

The role of interleukin-12 (IL-12) in Th1 cell differentiation is well established. The heterodimer p70, composed of a p40 and a p35 chain, is the biologically active form. IL-12 production by human monocytes is enhanced by interferon-gamma (IFN-gamma) and inhibited by IL-10 and prostaglandin E2 (PGE2). Peripheral blood mononuclear cells from human immunodeficiency virus (HIV)-infected individuals reportedly have impaired IL-12 p40 and p70 production on stimulation with Staphylococcus aureus Cowan I (SAC) in vitro. Both PGE2 and IL-10 previously were proposed to be instrumental in this defect in IL-12 production. Here, we studied IL-12 p40 and p70 production in relation to IL-10 and PGE2 production in whole blood cultures from HIV-infected individuals. On stimulation with lipopolysaccharide, IL-12 production was normal. However, on stimulation with SAC, IL-12 p40 and p70 production was decreased in HIV-infected individuals and correlated significantly with decreased peripheral blood CD4+ T-cell number and T-cell reactivity to CD3 monoclonal antibody in vitro. However, IL-10 and PGE2 production in cultures from HIV-infected individuals was normal and did not relate to IL-12 production. In conclusion, IL-12 production by cells from HIV-infected individuals is impaired under certain conditions in vitro and this decrease is independent of IL-10 or PGE2 production.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9002960

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Highly active antiretroviral therapy in patients infected with human immunodeficiency virus increases CD40 ligand expression and IL-12 production in cells ex vivo.

Authors:  Alice M Nyakeriga; Jun Ying; Norah J Shire; Carl J Fichtenbaum; Claire A Chougnet
Journal:  Viral Immunol       Date:  2011-08       Impact factor: 2.257

2.  Immune activation and IL-12 production during acute/early HIV infection in the absence and presence of highly active, antiretroviral therapy.

Authors:  Adriana A Byrnes; David M Harris; Sowsan F Atabani; Beulah P Sabundayo; Susan J Langan; Joseph B Margolick; Christopher L Karp
Journal:  J Leukoc Biol       Date:  2008-09-19       Impact factor: 4.962

Review 3.  Immune dysregulation and CD4+ T cell loss in HIV-1 infection.

Authors:  L Meyaard; F Miedema
Journal:  Springer Semin Immunopathol       Date:  1997

4.  Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.

Authors:  G Vanham; L Penne; J Devalck; L Kestens; R Colebunders; E Bosmans; K Thielemans; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

Review 5.  Interleukin-12 in infectious diseases.

Authors:  L Romani; P Puccetti; F Bistoni
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

6.  Plasma factors during chronic HIV-1 infection impair IL-12 secretion by myeloid dendritic cells via a virus-independent pathway.

Authors:  Elizabeth A Miller; Meredith R Spadaccia; Meagan P OʼBrien; Linda Rolnitzky; Rachel Sabado; Olivier Manches; Davor Frleta; Nina Bhardwaj
Journal:  J Acquir Immune Defic Syndr       Date:  2012-12-15       Impact factor: 3.731

Review 7.  Regulation of T helper cell subsets by cyclooxygenases and their metabolites.

Authors:  Hong Li; Matthew L Edin; Artiom Gruzdev; Jennifer Cheng; J Alyce Bradbury; Joan P Graves; Laura M DeGraff; Darryl C Zeldin
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-11-28       Impact factor: 3.072

8.  Cocaine alters cytokine profiles in HIV-1-infected African American individuals in the DrexelMed HIV/AIDS genetic analysis cohort.

Authors:  Nirzari Parikh; Will Dampier; Rui Feng; Shendra R Passic; Wen Zhong; Brian Frantz; Brandon Blakey; Benjamas Aiamkitsumrit; Vanessa Pirrone; Michael R Nonnemacher; Jeffrey M Jacobson; Brian Wigdahl
Journal:  J Acquir Immune Defic Syndr       Date:  2014-07-01       Impact factor: 3.731

9.  Histamine inhibits the production of interleukin-12 through interaction with H2 receptors.

Authors:  T C van der Pouw Kraan; A Snijders; L C Boeije; E R de Groot; A E Alewijnse; R Leurs; L A Aarden
Journal:  J Clin Invest       Date:  1998-11-15       Impact factor: 14.808

10.  Serum Cytokines Predict Neurological Damage in Genetically Diverse Mouse Models.

Authors:  Aracely A Pérez Gómez; Moumita Karmakar; Raymond J Carroll; Koedi S Lawley; Katia Amstalden; Colin R Young; David W Threadgill; C Jane Welsh; Candice Brinkmeyer-Langford
Journal:  Cells       Date:  2022-06-28       Impact factor: 7.666

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.